ライフサイエンスコーパス: posttraumatic stress disorder

1 s (i.e., general anxiety, depression, and/or posttraumatic stress disorder).

2 heimer's disease, Parkinson disease, stroke, posttraumatic stress disorder).

3 of Event Scale 15 item measuring symptoms of posttraumatic stress disorder.

4 illnesses like major depressive disorder and posttraumatic stress disorder.

5 spatial memory dysfunction in, for example, posttraumatic stress disorder.

6 ychiatric conditions, such as depression and posttraumatic stress disorder.

7 cessing (EMDR) is an effective treatment for posttraumatic stress disorder.

8 tion regulation in insomnia, depression, and posttraumatic stress disorder.

9 ess-related disorders, including anxiety and posttraumatic stress disorder.

10 ric conditions such as anxiety disorders and posttraumatic stress disorder.

11 nt of the patients showed a delayed onset of posttraumatic stress disorder.

12 riencing symptoms commensurate with clinical posttraumatic stress disorder.

13 to psychiatric disorders such as anxiety or posttraumatic stress disorder.

14 on, 33% for an anxiety disorder, and 26% for posttraumatic stress disorder.

15 assess symptoms of acute stress disorder and posttraumatic stress disorder.

16 underlie recurring anxiety disorders such as posttraumatic stress disorder.

17 ts were seen for ICU-diary interventions for posttraumatic stress disorder.

18 ajor depressive episode, panic disorder, and posttraumatic stress disorder.

19 mories in neuropsychiatric disorders such as posttraumatic stress disorder.

20 nction have been linked to trait anxiety and posttraumatic stress disorder.

21 oraphobia, obsessive-compulsive disorder, or posttraumatic stress disorder.

22 or the development of anxiety disorders like posttraumatic stress disorder.

23 ical populations, with a particular focus on posttraumatic stress disorder.

24 ive disorders including major depression and posttraumatic stress disorder.

25 hods for primary prevention and treatment of posttraumatic stress disorder.

26 onditions such as autism, schizophrenia, and posttraumatic stress disorder.

27 disrupted in psychiatric conditions such as posttraumatic stress disorder.

28 depressant for major depressive disorder and posttraumatic stress disorder.

29 qual to 35, indicating a high probability of posttraumatic stress disorder.

30 ium and symptoms of anxiety, depression, and posttraumatic stress disorder.

31 rium and symptoms of anxiety, depression, or posttraumatic stress disorder.

32 vant to spatial memory deficits described in posttraumatic stress disorder.

33 the memory of patients with schizophrenia or posttraumatic stress disorders.

34 ffects: first, ICU diaries reduced new-onset posttraumatic stress disorder (5% vs 13%, p = 0.02) afte

35 , 20.2%; generalized anxiety disorder, 7.9%; posttraumatic stress disorder, 9.8%; alcohol dependence,

36 ion, substance abuse, anxiety disorders, and posttraumatic stress disorder) a substantial subset of i

37 specific psychiatric disorders (depression, posttraumatic stress disorder, addiction, social anxiety

38 hose who screened positive for depression or posttraumatic stress disorder after return from deployme

39 has been associated with increased risk for posttraumatic stress disorder and affective disorders; t

40 New possibilities for treating posttraumatic stress disorder and anxiety disorders invo

41 pite significant overlap of symptoms between posttraumatic stress disorder and anxiety disorders, the

42 thasone compared with placebo on symptoms of posttraumatic stress disorder and depression and health-

43 nts, beneficial effects on the occurrence of posttraumatic stress disorder and depression may be pres

44 Posttraumatic stress disorder and depression were presen

45 nea and insomnia), mental health status (eg, posttraumatic stress disorder and depression), nonocular

46 seases; and mental health disorders, such as posttraumatic stress disorder and depression, that are a

47 e blast TBI was also observed on measures of posttraumatic stress disorder and depression.

48 stoperative admission to the ICU may lead to posttraumatic stress disorder and depression.

49 ively or negatively affect the prevalence of posttraumatic stress disorder and depression.

50 or the treatment of mental disorders such as posttraumatic stress disorder and drug addiction.

51 es in connectivity in patients with comorbid posttraumatic stress disorder and MDD.

52 a burden to daily life and characteristic of posttraumatic stress disorder and other anxiety disorder

53 responses and have been have been linked to posttraumatic stress disorder and other mental health af

54 le target in developing novel treatments for posttraumatic stress disorder and related disorders.

55 erapy for anxiety, obsessive-compulsive, and posttraumatic stress disorders and to evaluate whether a

56 pulsive disorder, major depressive disorder, posttraumatic stress disorder, and addiction.

57 chronic symptoms of postconcussive disorder, posttraumatic stress disorder, and depression and for th

58 eported symptoms of postconcussive disorder, posttraumatic stress disorder, and depression were deter

59 ast 6-month generalized anxiety disorder and posttraumatic stress disorder, and past 12-month alcohol

60 d comorbid conditions such as depression and posttraumatic stress disorder, and should be considered

61 tions, such as generalized anxiety disorder, posttraumatic stress disorder, and social anxiety disord

62 sment of aversive memory--a trait central to posttraumatic stress disorder--and a gene-set analysis i

63 Mental disorders (any disorder, mood, posttraumatic stress disorder, anxiety, alcohol use diso

64 Depression, posttraumatic stress disorder, anxiety, suicidal ideatio

65 SM-IV symptom criteria for major depression; posttraumatic stress disorder; anxiety disorder; suicida

66 s potential therapeutic effects for treating posttraumatic stress disorder are related to altering em

67 %, 42%, and 24% for depression, anxiety, and posttraumatic stress disorder) at 6 and 12 months.

68 hopathology (indiscriminate social behavior, posttraumatic stress disorder, attention-deficit/hyperac

69 ive disorders (mean scores >35), followed by posttraumatic stress disorder, borderline personality di

70 ocial outcomes (depression, anxiety, stress, posttraumatic stress disorder, burden, activity restrict

71 ew Version (PSS-I) and the stressor-specific Posttraumatic Stress Disorder Checklist (PCL-S); seconda

72 oms of posttraumatic stress (measured by the Posttraumatic Stress Disorder Checklist [PCL]), personal

73 outcomes were posttraumatic stress symptoms (Posttraumatic Stress Disorder Checklist for DSM-5), func

74 y the Neurobehavioral Symptom Inventory, the Posttraumatic Stress Disorder Checklist Military Version

75 onnaire) and post-traumatic stress symptoms (Posttraumatic Stress Disorder Checklist).

76 g the Patient Health Questionnaire-9 and the Posttraumatic Stress Disorder Checklist-Civilian version

77 substantial acute stress symptoms using the Posttraumatic Stress Disorder Checklist-Civilian version

78 Symptoms of posttraumatic stress disorder, depression, and health-re

79 antify the impact of psychiatric conditions (posttraumatic stress disorder, depression, anxiety, and

80 ty disorders, obsessive-compulsive disorder, posttraumatic stress disorder, depressive disorders, bip

81 ses including mild traumatic brain injury or posttraumatic stress disorder display alterations on ASL

82 Intelligence was not associated with posttraumatic stress disorder, eating disorders, and anx

83 Secondary outcomes included posttraumatic stress disorder experienced by the family

84 conversely, to the potential development of posttraumatic stress disorder following trauma.

85 The Psychiatric Genomics Consortium-Posttraumatic Stress Disorder group (PGC-PTSD) combined

86 co-occurring psychiatric conditions and with posttraumatic stress disorder having the largest impact.

87 polymorphism, rs4523957, is associated with posttraumatic stress disorder in humans, consistent with

88 that PACAP dysregulation is associated with posttraumatic stress disorder in humans.

89 health, increasing depression, anxiety, and posttraumatic stress disorder in these same villages.

90 he Impact of Event Scale was the most common posttraumatic stress disorder instrument.

91 Posttraumatic stress disorder is associated with an incr

92 Posttraumatic stress disorder is often comorbid with MDD

93 Four of these 5 ORs (posttraumatic stress disorder is the exception) predict

94 erapy for anxiety, obsessive-compulsive, and posttraumatic stress disorders is unclear.

95 younger, have more obesity, depression, and posttraumatic stress disorder, less obstructive coronary

96 h severe trauma-related psychopathology (ie, posttraumatic stress disorder, major depressive disorder

97 Posttraumatic stress disorder, major depressive episode,

98 Posttraumatic stress disorder manifests after exposure t

99 nisms of severe sepsis in the development of posttraumatic stress disorder need further examination.

100 roup analysis revealed a lower prevalence of posttraumatic stress disorder (odds ratio, 0.23; 95% CI,

101 nd 78 patients (13.8%) who received placebo (posttraumatic stress disorder: odds ratio, 0.82; 95% CI,

102 y a role in the formation and persistence of posttraumatic stress disorder, of which sleep impairment

103 There has been relatively little study of posttraumatic stress disorder or obsessive-compulsive di

104 of individuals severely exposed may develop posttraumatic stress disorder or other disorders.

105 lthough pathological fear, such as occurs in posttraumatic stress disorder or specific phobias, is al

106 (OR = 0.1 [95% CI, 0.0-0.8]), pre-enlistment posttraumatic stress disorder (OR = 0.1 [95% CI, 0.0-0.7

107 02), bipolar I (OR, 1.5; 95% CI, 1.06-2.05), posttraumatic stress disorder (OR, 1.6; 95% CI, 1.27-2.1

108 nalyses used a priori seeds relevant to TMS, posttraumatic stress disorder, or MDD (subgenual anterio

109 yment (depression: OR, 1.4; 95% CI, 1.1-1.9; posttraumatic stress disorder: OR, 2.4; 95% CI, 2.1-2.8)

110 increases in the rates of major depression; posttraumatic stress disorder; other anxiety disorders;

111 ntify anxiety, stress, caregiver burden, and posttraumatic stress disorder outcomes in informal careg

112 ssault-related injury (P<.001), diagnosis of posttraumatic stress disorder (P=.008), and diagnosis of

113 Posttraumatic stress disorder patients and traumatized c

114 of threat.SIGNIFICANCE STATEMENT Anxiety and posttraumatic stress disorder patients generalize fear t

115 Delayed-onset posttraumatic stress disorder (PTSD) accounts for approx

116 earlier trauma exposure is known to predict posttraumatic stress disorder (PTSD) after subsequent tr

117 f exposure to stressful experiences, such as posttraumatic stress disorder (PTSD) and depression, are

118 ehaviors, alcohol and drug use problems, and posttraumatic stress disorder (PTSD) and depressive symp

119 ittle is known about the association between posttraumatic stress disorder (PTSD) and disability into

120 an drive neuropsychiatric disorders, such as posttraumatic stress disorder (PTSD) and drug addiction.

121 ales disproportionately have higher rates of posttraumatic stress disorder (PTSD) and experience grea

122 tress reactivity is a predominant feature of posttraumatic stress disorder (PTSD) and may reflect dis

123 anding the neural causes and consequences of posttraumatic stress disorder (PTSD) and mild traumatic

124 ticipants (N=558) were assessed for probable posttraumatic stress disorder (PTSD) and probable depres

125 ticipants (N=558) were assessed for probable posttraumatic stress disorder (PTSD) and probable depres

126 Posttraumatic stress disorder (PTSD) appears to increase

127 Patients with posttraumatic stress disorder (PTSD) are at increased ri

128 s), obsessive-compulsive disorder (OCD), and posttraumatic stress disorder (PTSD) are common mental d

129 Patients with posttraumatic stress disorder (PTSD) are hyperresponsive

130 The current effective treatment options for posttraumatic stress disorder (PTSD) are limited, and th

131 tudies have found that those who suffer from posttraumatic stress disorder (PTSD) are more likely to

132 Psychological treatments for posttraumatic stress disorder (PTSD) are usually deliver

133 d was a significant risk for a high level of posttraumatic stress disorder (PTSD) arousal symptoms.

134 We prospectively examined posttraumatic stress disorder (PTSD) as a long-term cons

135 Posttraumatic stress disorder (PTSD) co-occurs with subs

136 e resilient to psychiatric disorders such as posttraumatic stress disorder (PTSD) compared with those

137 prazolam, compared with placebo, in reducing posttraumatic stress disorder (PTSD) due to military tra

138 Posttraumatic stress disorder (PTSD) has been associated

139 Posttraumatic stress disorder (PTSD) has been associated

140 atic brain injury (TBI) is a risk factor for posttraumatic stress disorder (PTSD) has been difficult

141 Posttraumatic stress disorder (PTSD) has been linked to

142 The limited neurobiological understanding of posttraumatic stress disorder (PTSD) has been partially

143 Previous evidence on endocrine correlates of posttraumatic stress disorder (PTSD) has been rather inc

144 Posttraumatic stress disorder (PTSD) has been shown to b

145 ncreasing predictability of animal models of posttraumatic stress disorder (PTSD) has required active

146 ifferential effects of maternal and paternal posttraumatic stress disorder (PTSD) have been observed

147 Evidence-based treatments for posttraumatic stress disorder (PTSD) have not been estab

148 or (alpha1AR) antagonist prazosin for combat posttraumatic stress disorder (PTSD) in 67 active duty s

149 h the proposal for a dissociative subtype of posttraumatic stress disorder (PTSD) in DSM-5 is support

150 lable from medical dispensaries for treating posttraumatic stress disorder (PTSD) in many states of t

151 the neurobiological mechanisms that predict posttraumatic stress disorder (PTSD) in recent trauma su

152 re to stress is a risk factor for developing posttraumatic stress disorder (PTSD) in response to trau

153 al blood during the onset and development of posttraumatic stress disorder (PTSD) indicate widespread

154 Posttraumatic stress disorder (PTSD) indicates a chronic

155 Posttraumatic stress disorder (PTSD) is a common conditi

156 Posttraumatic stress disorder (PTSD) is a common psychia

157 Posttraumatic stress disorder (PTSD) is a common psychia

158 Posttraumatic stress disorder (PTSD) is a common, debili

159 Posttraumatic stress disorder (PTSD) is a common, freque

160 Posttraumatic stress disorder (PTSD) is a debilitating d

161 Posttraumatic stress disorder (PTSD) is a debilitating p

162 Posttraumatic stress disorder (PTSD) is a disabling psyc

163 Posttraumatic stress disorder (PTSD) is a frequent anxie

164 Posttraumatic stress disorder (PTSD) is a heterogeneous

165 Posttraumatic stress disorder (PTSD) is a pervasive and

166 Posttraumatic stress disorder (PTSD) is a prevalent and

167 Posttraumatic stress disorder (PTSD) is a prevalent, ser

168 Posttraumatic stress disorder (PTSD) is a psychiatric il

169 Posttraumatic stress disorder (PTSD) is a relatively com

170 Posttraumatic stress disorder (PTSD) is a severe anxiety

171 Posttraumatic stress disorder (PTSD) is a severe, persis

172 Posttraumatic stress disorder (PTSD) is a stress-related

173 Posttraumatic stress disorder (PTSD) is associated with

174 Posttraumatic stress disorder (PTSD) is associated with

175 Posttraumatic stress disorder (PTSD) is both a prevalent

176 econsolidation marker.SIGNIFICANCE STATEMENT Posttraumatic stress disorder (PTSD) is characterized by

177 Posttraumatic stress disorder (PTSD) is considered a dis

178 The most effective treatment for posttraumatic stress disorder (PTSD) is exposure therapy

179 In the aftermath of a disaster, the risk of posttraumatic stress disorder (PTSD) is high.

180 The development of posttraumatic stress disorder (PTSD) is influenced by ge

181 Posttraumatic stress disorder (PTSD) is linked to elevat

182 Posttraumatic stress disorder (PTSD) is prevalent, persi

183 Although posttraumatic stress disorder (PTSD) is well studied amo

184 Maternal posttraumatic stress disorder (PTSD) may be associated w

185 Posttraumatic stress disorder (PTSD) may contribute to h

186 Posttraumatic stress disorder (PTSD) occurs in about 8%

187 ly described the paradoxical co-existence in posttraumatic stress disorder (PTSD) of sensory intrusiv

188 interactions between smoking and symptoms of posttraumatic stress disorder (PTSD) on pain intensity,

189 Medication and psychotherapy treatments for posttraumatic stress disorder (PTSD) provide insufficien

190 The neural substrates of pediatric posttraumatic stress disorder (PTSD) remain incompletely

191 Posttraumatic stress disorder (PTSD) results from the fo

192 verall symptoms in active-duty soldiers with posttraumatic stress disorder (PTSD) returned from comba

193 nced trauma and associated distress-that is, posttraumatic stress disorder (PTSD) severity-more than

194 Studies on posttraumatic stress disorder (PTSD) showing attentional

195 tivating polypeptide (PACAP) associated with posttraumatic stress disorder (PTSD) symptoms in a highl

196 The efficacy of posttraumatic stress disorder (PTSD) treatments in psych

197 theater veterans with a high probability of posttraumatic stress disorder (PTSD) were nearly 2 times

198 ated sufficient efficacy in the treatment of posttraumatic stress disorder (PTSD), a chronic and disa

199 s process a potential therapeutic target for posttraumatic stress disorder (PTSD), a mental illness c

200 Genetic factors influence the risk for posttraumatic stress disorder (PTSD), a potentially chro

201 of NPY with trauma-evoked syndromes such as posttraumatic stress disorder (PTSD), although the exact

202 Hippocampus atrophy is implicated in posttraumatic stress disorder (PTSD), and may partly ref

203 ent among veterans, especially veterans with posttraumatic stress disorder (PTSD), and poses a major

204 sychiatric disorders, such as depression and posttraumatic stress disorder (PTSD), are inadequate.

205 Since the inception of the diagnosis posttraumatic stress disorder (PTSD), attempts have been

206 posure therapy is an effective treatment for posttraumatic stress disorder (PTSD), but a comprehensiv

207 smaller hippocampal and amygdala volumes in posttraumatic stress disorder (PTSD), but findings have

208 posure therapy is an effective treatment for posttraumatic stress disorder (PTSD), but many patients

209 to underlie the pathophysiology of pediatric posttraumatic stress disorder (PTSD), but the few studie

210 al patterns of spontaneous brain activity in posttraumatic stress disorder (PTSD), but the findings a

211 r (GR) sensitivity is present in people with posttraumatic stress disorder (PTSD), but the molecular

212 n array of pathological conditions including posttraumatic stress disorder (PTSD), characterized by d

213 d C-reactive protein, have been described in posttraumatic stress disorder (PTSD), generalized anxiet

214 erapy (CPT), an evidence-based treatment for posttraumatic stress disorder (PTSD), has not been teste

215 e genetic basis of three disorder categories-posttraumatic stress disorder (PTSD), major depressive d

216 est were 30-day prevalence postdeployment of posttraumatic stress disorder (PTSD), major depressive e

217 eneralization of fear, a cardinal feature of posttraumatic stress disorder (PTSD), manifests as inapp

218 g major depressive disorder, panic disorder, posttraumatic stress disorder (PTSD), oppositional-defia

219 (REM) sleep disturbances are the hallmark of posttraumatic stress disorder (PTSD), proposed by Ross a

220 re-based therapy, an effective treatment for posttraumatic stress disorder (PTSD), relies on extincti

221 In about 30-50% of patients with posttraumatic stress disorder (PTSD), symptoms persist a

222 factor for cardiovascular disease (CVD), and posttraumatic stress disorder (PTSD), the sentinel stres

223 for developing anxiety disorders, including posttraumatic stress disorder (PTSD), the underlying mec

224 ng a genome-wide association study (GWAS) of posttraumatic stress disorder (PTSD), we report that het

225 unclear whether such models are relevant to posttraumatic stress disorder (PTSD), which has been lin

226 Posttraumatic stress disorder (PTSD), while highly preva

227 tion to threat is perturbed in patients with posttraumatic stress disorder (PTSD), with some studies

228 Posttraumatic stress disorder (PTSD)-a chronic, debilita

229 identified a role of leaky neuronal RyR2 in posttraumatic stress disorder (PTSD).

230 tric disorders, and is a defining feature of posttraumatic stress disorder (PTSD).

231 f quetiapine monotherapy in the treatment of posttraumatic stress disorder (PTSD).

232 s modulatory transmitter, is associated with posttraumatic stress disorder (PTSD).

233 nimal model of traumatic memory formation in posttraumatic stress disorder (PTSD).

234 n considered imperative in psychotherapy for posttraumatic stress disorder (PTSD).

235 onfer an increased incidence and severity of posttraumatic stress disorder (PTSD).

236 ce to existing evidence-based treatments for posttraumatic stress disorder (PTSD).

237 stress during a traumatic event may lead to posttraumatic stress disorder (PTSD).

238 e variability (HRV) has been associated with posttraumatic stress disorder (PTSD).

239 d its dysfunction potentially contributes to posttraumatic stress disorder (PTSD).

240 extinction learning are believed to sustain posttraumatic stress disorder (PTSD).

241 tress develop over time into the syndrome of posttraumatic stress disorder (PTSD).

242 otein (CRP) are elevated in individuals with posttraumatic stress disorder (PTSD).

243 tor for later life anxiety disorders such as posttraumatic stress disorder (PTSD).

244 ilance and symptoms of heightened arousal in posttraumatic stress disorder (PTSD).

245 stress, and as a result, many have developed posttraumatic stress disorder (PTSD).

246 y few preventive interventions available for posttraumatic stress disorder (PTSD).

247 d stress-associated mental illnesses such as posttraumatic stress disorder (PTSD).

248 adian misalignment in the pathophysiology of posttraumatic stress disorder (PTSD).

249 tanding the pathophysiology and treatment of posttraumatic stress disorder (PTSD).

250 the risk of mental health problems, such as posttraumatic stress disorder (PTSD).

251 n in peripheral blood cells in patients with posttraumatic stress disorder (PTSD).

252 e development of psychiatric illness such as posttraumatic stress disorder (PTSD).

253 ss-associated syndromes, most prototypically posttraumatic stress disorder (PTSD).

254 insufficient to reduce the burden of chronic posttraumatic stress disorder (PTSD).

255 ences, including their propensity to develop posttraumatic stress disorder (PTSD).

256 is widely accepted as a pathogenic marker of posttraumatic stress disorder (PTSD).

257 g in the formation of indelible memories and posttraumatic stress disorder (PTSD).

258 ala reactivity is a vulnerability factor for posttraumatic stress disorder (PTSD); however, our under

259 sing a locally validated version of the UCLA Posttraumatic Stress Disorder Reaction Index (range, 0-4

260 disorder (RR, 1.29 [95% CI, 1.01-1.65]), and posttraumatic stress disorder (RR, 1.47 [95% CI, 1.09-1.

261 (OR, 1.15; 95% CI, 1.02-1.30; P = .02), and posttraumatic stress disorder score (OR, 1.04; 95% CI, 1

262 fied between overall DE symptom severity and posttraumatic stress disorder scores and tear breakup ti

263 Subjects with posttraumatic stress disorder show impaired extinction o

264 suicidal plan, bipolar disorder, psychosis, posttraumatic stress disorder, substance dependence, cur

265 ation manual was associated with significant posttraumatic stress disorder symptom reduction at 2 mon

266 ent negative life events, and depressive and posttraumatic-stress-disorder symptom scores with placen

267 e pooled prevalences of clinically important posttraumatic stress disorder symptoms (95% CI) were 25%

268 ationship to whole-brain cortical thickness, posttraumatic stress disorder symptoms (PTSD) and depres

269 Substantial posttraumatic stress disorder symptoms at 3 months post-

270 turned out to be a significant predictor of posttraumatic stress disorder symptoms at 3-month follow

271 atients with general anxiety, depression, or posttraumatic stress disorder symptoms during 2-year fol

272 lihood of remission from general anxiety and posttraumatic stress disorder symptoms during follow-up.

273 e individuals, increased lifetime stress and posttraumatic stress disorder symptoms explained the maj

274 ICU risk factors for posttraumatic stress disorder symptoms included benzodia

275 Clinically important posttraumatic stress disorder symptoms occurred in one f

276 rathreshold general anxiety, depression, and posttraumatic stress disorder symptoms ranged from 38% t

277 ore was 17 (9-24), and pooled prevalences of posttraumatic stress disorder symptoms were 17% (10-26%)

278 Substantial depressive and posttraumatic stress disorder symptoms were assessed usi

279 Posttraumatic stress disorder symptoms were associated w

280 Posttraumatic stress disorder symptoms were higher in th

281 vised (scores >/= 1.6 indicating substantial posttraumatic stress disorder symptoms).

282 s associated with a significant reduction in posttraumatic stress disorder symptoms, 2) a self-help r

283 significant general anxiety, depression, or posttraumatic stress disorder symptoms, and these sympto

284 r depression symptoms and may have increased posttraumatic stress disorder symptoms.

285 subsequent remission of general anxiety and posttraumatic stress disorder symptoms.

286 urse-led ICU follow-up clinic did not reduce posttraumatic stress disorder symptoms.

287 imultaneous general anxiety, depression, and posttraumatic stress disorder symptoms.

288 In European studies, ICU diaries reduced posttraumatic stress disorder symptoms.

289 tors, but with more obesity, depression, and posttraumatic stress disorder than men.

290 acotherapies and device-based treatments for posttraumatic stress disorder that have been developed v

291 memories underlie anxiety disorders, such as posttraumatic stress disorder, the key neural and molecu

292 Posttraumatic stress disorder was assessed by the Short

293 Posttraumatic stress disorder was found in 7% of the pat

294 Posttraumatic stress disorder was identified using the C

295 Acute stress disorder and posttraumatic stress disorder were diagnosed according t

296 lthough symptoms of anxiety, depression, and posttraumatic stress disorder were found to be common 1

297 ental Disorders (version IV) Criterion A for posttraumatic stress disorder were interviewed.

298 lence and arrests, and anger associated with posttraumatic stress disorder) were chosen based on empi

299 h symptom levels of depression, anxiety, and posttraumatic stress disorder, which are strongly associ

300 Five of these trials assessed posttraumatic stress disorder, with four trials showing